UK markets closed

Utah Medical Products, Inc. (UTMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.72-0.73 (-1.04%)
At close: 04:00PM EDT
69.72 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
16,377
16,635
16,473
14,788
10,798
Depreciation & amortisation
7,214
6,368
7,082
7,284
7,209
Deferred income taxes
-863
-681
-395
-53
-19
Stock-based compensation
254
225
183
166
160
Change in working capital
-371
-233
-2,226
-1,006
1,993
Accounts receivable
-
2,270
-511
-1,088
617
Inventory
685
-670
-2,353
-485
924
Accounts payable
-33
-456
464
-23
-308
Other working capital
20,024
21,642
20,329
20,651
19,277
Net cash provided by operating activities
20,642
22,281
21,147
21,203
20,137
Cash flows from investing activities
Investments in property, plant and equipment
-618
-639
-818
-552
-860
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-591
-639
-818
-552
-860
Cash flows from financing activities
Common stock repurchased
-2,990
0
-2,495
0
-6,976
Dividends paid
-4,301
-4,282
-3,163
-11,465
-4,116
Net cash used provided by (used for) financing activities
-7,099
-4,165
-5,484
-10,905
-10,734
Net change in cash
12,896
17,816
14,078
9,384
8,803
Cash at beginning of period
80,912
75,052
60,974
51,590
42,787
Cash at end of period
93,864
92,868
75,052
60,974
51,590
Free cash flow
Operating cash flow
20,642
22,281
21,147
21,203
20,137
Capital expenditure
-618
-639
-818
-552
-860
Free cash flow
20,024
21,642
20,329
20,651
19,277